Mind Medicine Inc (MNMD NASDAQ) stock market data APIs
$9.6093
0.12(1.2%)
as of September 17, 2025
Try our APIs with
free plan!
Mind Medicine Inc Financial Data Overview
Price chart is built with
Anychart
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Prev. Close
9.6093
Open
9.7342
High
10.0675
Low
9.408
52 wk Range
4.7-11.02
Market Cap
739 M
Shares Outstanding
76 088 K
EPS
-0.5
Beta
2.966
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mind Medicine Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mind Medicine Inc data using free add-ons & libraries
Get Mind Medicine Inc Fundamental Data
Mind Medicine Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -130 802 496
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-31
- EPS/Forecast: -0.37
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mind Medicine Inc News
New
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
Key Points Mind Medicine stock is a speculative play on future potential for psychedelics as therapeutic treatments. The stock has underperformed the S&P 500 over the last five years, but it has sti...
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
Key Points Mind Medicine stock is a speculative play on future potential for psychedelics as therapeutic treatments. The stock has underperformed the S&P 500 over the last five years, but it has stil...
MindMed Reports Strong Q2 2025 Results
Mind Medicine (MindMed)(NASDAQ:MNMD) reported Q2 2025 results on July 31, 2025. The company maintained strong enrollment momentum across all three pivotal phase 3 trials for MM120 ODT, confirmed a cas...
1 Reason to Buy MindMed (MNMD)
Key Points The company must operate under strict regulations, as it is developing certain medicines based on psychedelic substances. Such compounds are currently illegal for sale or consumption throu...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
